NanoViricidesNNVC
About: Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
Employees: 7
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
113% more call options, than puts
Call options by funds: $49K | Put options by funds: $23K
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
0.04% less ownership
Funds ownership: 11.39% [Q2] → 11.34% (-0.04%) [Q3]
9% less funds holding
Funds holding: 34 [Q2] → 31 (-3) [Q3]
13% less capital invested
Capital invested by funds: $2.31M [Q2] → $2.01M (-$303K) [Q3]
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Research analyst outlook
We haven’t received any recent analyst ratings for NNVC.
Financial journalist opinion
Based on 4 articles about NNVC published over the past 30 days
